Regulation of proliferation, differentiation and functions of osteoblasts by Runx2
T Komori - International journal of molecular sciences, 2019 - mdpi.com
Runx2 is essential for osteoblast differentiation and chondrocyte maturation. During
osteoblast differentiation, Runx2 is weakly expressed in uncommitted mesenchymal cells …
osteoblast differentiation, Runx2 is weakly expressed in uncommitted mesenchymal cells …
Functional relationship between osteogenesis and angiogenesis in tissue regeneration
F Diomede, GD Marconi, L Fonticoli… - International Journal of …, 2020 - mdpi.com
Bone tissue renewal can be outlined as a complicated mechanism centered on the
interaction between osteogenic and angiogenic events capable of leading to bone formation …
interaction between osteogenic and angiogenic events capable of leading to bone formation …
Runx2: Structure, function, and phosphorylation in osteoblast differentiation
Runx2 is a master transcription factor for osteogenesis. The most important phenomenon
that makes this protein a master regulator for osteogenesis is its structural integrity. In …
that makes this protein a master regulator for osteogenesis is its structural integrity. In …
p38 MAPK signaling in osteoblast differentiation
E Rodríguez-Carballo, B Gámez… - Frontiers in cell and …, 2016 - frontiersin.org
The skeleton is a highly dynamic tissue whose structure relies on the balance between bone
deposition and resorption. This equilibrium, which depends on osteoblast and osteoclast …
deposition and resorption. This equilibrium, which depends on osteoblast and osteoclast …
[HTML][HTML] Focus on the p38 MAPK signaling pathway in bone development and maintenance
C Thouverey, J Caverzasio - BoneKEy reports, 2015 - ncbi.nlm.nih.gov
The p38 mitogen-activated protein kinase (MAPK) signaling pathway can be activated in
response to a wide range of extracellular signals. As a consequence, it can generate many …
response to a wide range of extracellular signals. As a consequence, it can generate many …
[HTML][HTML] NRF2 function in osteocytes is required for bone homeostasis and drives osteocytic gene expression
C Sánchez-de-Diego, L Pedrazza, C Pimenta-Lopes… - Redox biology, 2021 - Elsevier
Osteocytes, the most abundant bone cell type, are derived from osteoblasts through a
process in which they are embedded in an osteoid. We previously showed that nutrient …
process in which they are embedded in an osteoid. We previously showed that nutrient …
Sp7/Osterix is restricted to bone-forming vertebrates where it acts as a Dlx co-factor in osteoblast specification
In extant species, bone formation is restricted to vertebrate species. Sp7/Osterix is a key
transcriptional determinant of bone-secreting osteoblasts. We performed Sp7 chromatin …
transcriptional determinant of bone-secreting osteoblasts. We performed Sp7 chromatin …
Calycosin-7-O-β-Glucoside Isolated from Astragalus membranaceus Promotes Osteogenesis and Mineralization in Human Mesenchymal Stem Cells
KR Park, JE Park, B Kim, IK Kwon, JT Hong… - International Journal of …, 2021 - mdpi.com
Stem cells have received attention in various diseases, such as inflammatory, cancer, and
bone diseases. Mesenchymal stem cells (MSCs) are multipotent stem cells that are critical …
bone diseases. Mesenchymal stem cells (MSCs) are multipotent stem cells that are critical …
Mg2+ in β‐TCP/Mg–Zn composite enhances the differentiation of human bone marrow stromal cells into osteoblasts through MAPK‐regulated Runx2/Osx
Z Wang, Q Liu, C Liu, W Tan, M Tang… - Journal of Cellular …, 2020 - Wiley Online Library
Inducing the osteogenic differentiation from bone marrow stromal cells (BMSCs) might be a
potent strategy for treating bone loss and nonunion during fracture and improving fracture …
potent strategy for treating bone loss and nonunion during fracture and improving fracture …
Antiosteoporosis effects, pharmacokinetics, and drug delivery systems of icaritin: advances and prospects
L Gao, SQ Zhang - Pharmaceuticals, 2022 - mdpi.com
Osteoporosis is a systemic skeletal disorder affecting over 200 million people worldwide and
contributes dramatically to global healthcare costs. Available anti-osteoporotic drug …
contributes dramatically to global healthcare costs. Available anti-osteoporotic drug …